CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash Flows from Operating Activities:
Net (loss) income	$ (22,026)	$ 99,824
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization (including amortization of deferred financing costs)	124,083	121,265
Straight-lining of rents	(26,210)	(4,299)
Distributions of income from partially owned entities	23,710	28,382
Equity in net income of partially owned entities	(12,822)	(96,977)
Stock-based compensation expense	5,655	6,022
Change in deferred tax liability	2,989	3,084
Amortization of below-market leases, net	(101)	(88)
Amortization of interest rate cap premiums	62	7,726
Net gains on disposition of wholly owned and partially owned assets	0	(15,551)
Other non-cash adjustments	4,242	5,011
Changes in operating assets and liabilities:
Tenant and other receivables	(22,830)	(13,424)
Prepaid assets	(64,575)	(53,578)
Other assets	18,618	(38,234)
Lease liabilities	(1,574)	(15,636)
Accounts payable and accrued expenses	18,091	19,567
Other liabilities	435	(1,060)
Net cash provided by operating activities	47,747	52,034
Cash Flows from Investing Activities:
Acquisitions of real estate and other	(171,840)	0
Proceeds from repayment of loan receivable	85,000	0
Additions to real estate	(65,989)	(42,192)
Investments in partially owned entities	(41,163)	(12,284)
Development costs and construction in progress	(36,284)	(40,934)
Distributions of capital from partially owned entities	350	0
Proceeds from partial redemption of Fifth Avenue and Times Square JV preferred equity	0	342,000
Proceeds from sale of condominium units and ancillary amenities at 220 Central Park South	0	24,713
Proceeds from sales of real estate and other	0	4,198
Net cash (used in) provided by investing activities	(229,926)	275,501
Cash Flows from Financing Activities:
Proceeds from borrowings	1,514,781	120,000
Repayments of borrowings	(968,081)	(574,368)
Repurchase of common shares	(79,899)	0
Deferred financing costs	(35,137)	0
Dividends paid on preferred shares	(15,525)	(15,526)
Distributions to noncontrolling interests	(107)	(504)
Contributions from noncontrolling interests	0	53
Other financing activity, net	117	79
Net cash provided by (used in) financing activities	416,149	(470,266)
Net increase (decrease) in cash and cash equivalents and restricted cash	233,970	(142,731)
Cash and cash equivalents and restricted cash at beginning of period	977,546	949,619
Cash and cash equivalents and restricted cash at end of period	1,211,516	806,888
Reconciliation of Cash and Cash Equivalents and Restricted Cash:
Cash and cash equivalents at beginning of period	840,850	733,947
Restricted cash at beginning of period	136,696	215,672
Cash and cash equivalents and restricted cash	1,211,516	806,888
Cash and cash equivalents at end of period	1,081,299	568,861
Restricted cash at end of period	130,217	238,027
Supplemental Disclosure of Cash Flow Information:
Cash payments for interest (excluding capitalized interest) and interest rate cap premiums	69,255	83,422
Cash payments for income taxes	2,643	1,800
Non-Cash Information:
Redeemable Class A unit measurement adjustment	113,502	54,535
Write-off of fully depreciated assets	(22,853)	(23,280)
Accrued capital expenditures included in accounts payable and accrued expenses	18,507	22,890
Change in fair value of consolidated interest rate hedges and other	$ 12,406	$ (26,062)